(Q40727296)

23 September 2017

title

Influence of Pharmacokinetic and Pharmacodynamic Principles on Antibiotic Selection (English)

1 reference

23 September 2017

1 reference

1 reference

1

George G. Zhanel

1 reference

23 September 2017

publication date

1 February 2001

1 reference

Current infectious disease reports

23 September 2017

published in

1 reference

23 September 2017

volume

3

1 reference

23 September 2017

issue

1

1 reference

23 September 2017

page(s)

29-34

1 reference

Subinhibitory antimicrobial concentrations: A review of in vitro and in vivo data

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-001-0056-X

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-001-0056-X

The new fluoroquinolones: A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-001-0056-X

A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: the Alexander Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-001-0056-X

Evolving patterns of resistance to respiratory pathogens in Canada.

21 January 2018

1 reference

12 December 2020

Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis

1 reference

12 December 2020

Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae

1 reference

12 December 2020

Pharmacodynamics to combat resistance

1 reference

12 December 2020

Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.

1 reference

12 December 2020

The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of fluoroquinolones

1 reference

12 December 2020

Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of antibiotics in otitis media

1 reference

12 December 2020

Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy

1 reference

12 December 2020

Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection

1 reference

12 December 2020

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group

1 reference

12 December 2020

In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations.

1 reference

12 December 2020

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

1 reference

12 December 2020

Comparative activities of ciprofloxacin and levofloxacin against Streptococcus pneumoniae in an In vitro dynamic model

1 reference

12 December 2020

Relevance of the Alexander Project: pharmacodynamic considerations

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

1 reference

12 December 2020

Efficacy of beta-lactam antibiotics: integration of pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Increasing antibiotic resistance among otitis media pathogens and their susceptibility to oral agents based on pharmacodynamic parameters

1 reference

12 December 2020

Pharmacodynamics and pharmacokinetics of levofloxacin

1 reference

12 December 2020

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

1 reference

12 December 2020

Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance

1 reference

12 December 2020

Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides

1 reference

12 December 2020

Activity of moxifloxacin, administered once a day, against Streptococcus pneumoniae in an in vitro pharmacodynamic model of infection

1 reference

12 December 2020

Comparison of the fluoroquinolones based on pharmacokinetic and pharmacodynamic parameters

1 reference

12 December 2020

Antibacterial use in community practice: assessing quantity, indications and appropriateness, and relationship to the development of antibacterial resistance

1 reference

12 December 2020

Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group

1 reference

12 December 2020

10.1007/S11908-001-0056-X

Identifiers

DOI

1 reference

23 September 2017

1 reference